<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0376480" disease_type="Disease or Syndrome" abbrv="">Gingival enlargement</z:e> is common among patients and can be caused by a variety of etiological factors </plain></SENT>
<SENT sid="1" pm="."><plain>The most common reason is poor oral hygiene and high <z:mp ids='MP_0001794'>bacterial</z:mp> load that leads to gingival <z:mp ids='MP_0001845'>inflammation</z:mp> and enlargement </plain></SENT>
<SENT sid="2" pm="."><plain>Other implicated factors include systemic drugs, such as phenytoin (Dilantin) taken by <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> patients, <z:chebi fb="0" ids="38215">calcium channel blockers</z:chebi> such as <z:chebi fb="1" ids="7565">nifedipine</z:chebi> (<z:chebi fb="0" ids="7565">Procardia</z:chebi>) and <z:chebi fb="1" ids="9948">verapamil</z:chebi> (Calan) for the treatment of <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> and <z:mp ids='MP_0006112'>angina</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Another class of medication associated with <z:e sem="disease" ids="C0376480" disease_type="Disease or Syndrome" abbrv="">gingival enlargement</z:e> is <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> given to organ-transplant patients to prevent rejection of the new element such as <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Some enlargements could be associated with other conditions such as puberty, pregnancy or <z:mp ids='MP_0002055'>diabetes</z:mp> or be a symptom of a <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> (<z:hpo ids='HP_0001909'>leukemia</z:hpo>, Wegener's <z:hpo ids='HP_0002955'>granulomatosis</z:hpo> or <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e>) </plain></SENT>
<SENT sid="5" pm="."><plain>In rare cases the cause for the enlargement is genetic and termed hereditary <z:hpo ids='HP_0000169'>gingival fibromatosis</z:hpo> (HGF) </plain></SENT>
<SENT sid="6" pm="."><plain>HGF is a <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorder</z:e> characterized by a progressive enlargement of the gingiva </plain></SENT>
<SENT sid="7" pm="."><plain>Histologically, the gingiva is characterized by an accumulation of dense fibrous connective tissue </plain></SENT>
<SENT sid="8" pm="."><plain>This is believed to be due to an imbalance between synthesis and degradation of extracellular matrix composed mainly of collagen molecules or due to an alteration in <z:mpath ids='MPATH_180'>fibroblast proliferation</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Different pathogenic mechanisms have been proposed and examined over the years but no precise process has been identified </plain></SENT>
<SENT sid="10" pm="."><plain>The main objective of this paper is to discuss this genetic anomaly and support it with clinical cases of a mother and her two children </plain></SENT>
<SENT sid="11" pm="."><plain>It will focus on the clinical and histologic characteristics of HGF as well as known biologic and genetic features and treatment modalities </plain></SENT>
</text></document>